 "pharma GCCs in India, AI in drug discovery India, generative AI in pharma, AI in clinical trials India, pharmaceutical global capability centres, personalised medicine using AI, AI in healthcare India, reducing drug development time AI, AI in pharmac")
Pharmaceutical global capability centres (GCCs) in India are emerging as critical hubs in the global effort to cut drug development timelines and costs, thanks to the accelerated adoption of artificial intelligence (AI) and generative AI (GenAI).
From early-stage discovery to clinical trial optimisation and regulatory processes, GCCs are co-creating AI solutions that are reshaping how drugs and therapies are developed.
“The process of ideation to getting a medicine in a patient’s hand is a 10 to 14-year process, but with artificial intelligence (AI), it will be reduced by 50 per cent. We should be able to see a higher success
